[Edaily Starin YUN GI BACK Reporter] The group ENHYPEN has once again demonstrated its unwavering commercial success by surpassing 2 million first-week sales with its new album. Despite a lineup change, the group achieved the remarkable feat of becoming a double million-seller for the fifth time. ENHYPEN (Photo: Belief Lab) According to Hanteo Chart on the 28th, ENHYPEN’s 8th mini-album “THE SIN: BLISS” sold a total of 2,099,048 copies during its first week of release, from the 21st to the 27th. By surpassing 2 million copies in just one week, the group achieved its fifth double million-seller to date. What stands out is their consistent album sales. All of N.HYPEN’s mini-albums 5 through 8 and their second full-length album, released in Korea over the past three years, have surpassed cumulative sales of 2 million copies. In particular, this eighth mini-album surpassed 2 million copies in just its first week of release, reaffirming the strong purchasing power of N.HYPEN’s fanbase. The album’s strong performance in Korea has carried over to Japan. “The X: Bliss” debuted at No. 1 on the Oricon “Daily Album Ranking” on the 25th and maintained the top spot on the chart dated the 26th. By achieving strong first-week sales in Korea and charting success in Japan simultaneously, the group has demonstrated its presence in major music markets. Not only the album but also the title track “Bloody Paradise” is achieving success. ENHYPEN took first place on Mnet’s “M Countdown,” which aired on the 27th, securing their second music show victory during this promotional run. The ENHYPEN members shared their thoughts, saying, “We put a lot of effort and hard work into preparing this album, so we’re happy to have taken first place,” adding, “We’ll continue to be an ENHYPEN that can bring you even more amazing albums in the future.”
SamsungElectronics Chairman Jay Y. Lee is set to receive a gift of SamsungElectronics stock worth approximately 2.6 trillion won from his mother, Hong Ra-hee, Honorary Director of the Leeum Museum of …
Jeong Ki-seon, Chairman of HD Hyundai. (Photo courtesy of HD Hyundai)
HD Hyundai will unveil its self-developed humanoid robot for the first time next week. This is part of a strategy to break awa…
The outcome of the nine-year-long dispute over botulinum toxin strains between Medy-Tox Inc.(086900)and DAEWOONGPHARMACEUTICAL(069620)will be announced in January of next year.Industry observers expec…